Oct. 20, 2026 — Johnson & Johnson has announced the U.S. launch of its Shockwave C2 Aero Fly Coronary IVL catheter designed to treat a broad range of calcified coronary artery lesions in half the time ...
Oct.19, 2026 – Jupiter Endovascular has announced publication of full results from its SPIRARE II pivotal trial ...
Oct. 20, 2026 — Johnson & Johnson has announced the U.S. launch of its Shockwave C2 Aero Fly Coronary IVL catheter ...
Oct. 14, 2026 — GLP-1 weight loss drugs known may help protect against heart failure even at doses too low to produce ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
Oct. 14, 2026 — W. L. Gore & Associates' medical business has announced U.S. Food and Drug Administration approval of an ...
Medical device portfolios now move on two very different clocks. New technologies can gain clinical adoption within ...
Oct. 12, 2026 — Endovascular Engineering (E2) has announced that the U.S. Food and Drug Administration (FDA) has granted ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
Oct. 12, 2026 — The American Heart Association has expanded its education portfolio to help clinicians put the new ...
Oct. 12, 2026 — Siemens Healthineers announced it ultrasound business plans to concentrate its efforts on cardiovascular ...
Oct. 6, 2026 — Penumbra, Inc. has announced results from a subset analysis of the landmark STORM-PE randomized ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Oct. 8, 2026 – At the Heart Failure Society of America (HFSA) Annual Scientific Meeting in Phoenix, Arizona, Bayer ...
Oct. 8, 2026 — Government officials, global health leaders, clinicians, patient advocates, professional societies and ...
Oct. 6, 2026 — Riverain Technologies has announced that its FDA-cleared ClearRead Chest suite will be available through ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Oct. 7, 2026 — Boston Scientific Corp. has appointed Joseph M. Fitzgerald to executive vice president and chief ...
Oct. 5, 2026 — Abbott has announced U.S. Food and Drug Administration (FDA) approval for updates to the CardioMEMS HF ...
Oct. 5, 2026 – Endologix Holdings, LLC has announced Rhevera Medical as its new corporate brand. The new identity ...
October 20, 2026
